nodes	percent_of_prediction	percent_of_DWPC	metapath
L-DOPA—restless legs syndrome—Gabapentin—migraine	0.398	0.695	CpDpCtD
L-DOPA—Parkinson's disease—Gabapentin—migraine	0.175	0.305	CpDpCtD
L-DOPA—DRD3—Amitriptyline—migraine	0.0743	0.403	CbGbCtD
L-DOPA—DRD2—Amitriptyline—migraine	0.0435	0.236	CbGbCtD
L-DOPA—CYP2D6—Timolol—migraine	0.0204	0.11	CbGbCtD
L-DOPA—CYP2D6—Propranolol—migraine	0.0182	0.0984	CbGbCtD
L-DOPA—CYP2D6—Amitriptyline—migraine	0.0157	0.0851	CbGbCtD
L-DOPA—CYP2D6—Verapamil—migraine	0.0125	0.0676	CbGbCtD
L-DOPA—DDC—pineal body—migraine	0.00299	0.0768	CbGeAlD
L-DOPA—DDC—nerve—migraine	0.00217	0.0558	CbGeAlD
L-DOPA—PSIP1—neck—migraine	0.00214	0.055	CbGeAlD
L-DOPA—PSIP1—trigeminal ganglion—migraine	0.00185	0.0475	CbGeAlD
L-DOPA—PSIP1—brainstem—migraine	0.00164	0.042	CbGeAlD
L-DOPA—DRD1—nerve—migraine	0.0016	0.041	CbGeAlD
L-DOPA—SLC7A8—neck—migraine	0.00141	0.0362	CbGeAlD
L-DOPA—PSIP1—cardiovascular system—migraine	0.00134	0.0343	CbGeAlD
L-DOPA—SLC7A5—trigeminal ganglion—migraine	0.000944	0.0242	CbGeAlD
L-DOPA—DRD2—nerve—migraine	0.000944	0.0242	CbGeAlD
L-DOPA—DDC—brainstem—migraine	0.000933	0.024	CbGeAlD
L-DOPA—PSIP1—head—migraine	0.000904	0.0232	CbGeAlD
L-DOPA—PSIP1—nervous system—migraine	0.000857	0.022	CbGeAlD
L-DOPA—SLC16A10—neck—migraine	0.000838	0.0215	CbGeAlD
L-DOPA—PSIP1—central nervous system—migraine	0.000825	0.0212	CbGeAlD
L-DOPA—PSIP1—cerebellum—migraine	0.000807	0.0207	CbGeAlD
L-DOPA—DRD1—brainstem—migraine	0.000686	0.0176	CbGeAlD
L-DOPA—SLC7A5—cardiovascular system—migraine	0.000682	0.0175	CbGeAlD
L-DOPA—PSIP1—brain—migraine	0.000655	0.0168	CbGeAlD
L-DOPA—SLC7A8—head—migraine	0.000596	0.0153	CbGeAlD
L-DOPA—SLC7A8—nervous system—migraine	0.000565	0.0145	CbGeAlD
L-DOPA—DRD4—brain—migraine	0.000545	0.014	CbGeAlD
L-DOPA—SLC7A8—central nervous system—migraine	0.000544	0.014	CbGeAlD
L-DOPA—SLC7A8—cerebellum—migraine	0.000532	0.0137	CbGeAlD
L-DOPA—DRD3—head—migraine	0.000529	0.0136	CbGeAlD
L-DOPA—DDC—head—migraine	0.000516	0.0132	CbGeAlD
L-DOPA—DRD3—nervous system—migraine	0.000502	0.0129	CbGeAlD
L-DOPA—DRD5—head—migraine	0.000496	0.0127	CbGeAlD
L-DOPA—DDC—nervous system—migraine	0.000489	0.0126	CbGeAlD
L-DOPA—DRD3—central nervous system—migraine	0.000483	0.0124	CbGeAlD
L-DOPA—DDC—central nervous system—migraine	0.000471	0.0121	CbGeAlD
L-DOPA—DRD5—nervous system—migraine	0.00047	0.0121	CbGeAlD
L-DOPA—SLC7A5—head—migraine	0.000462	0.0119	CbGeAlD
L-DOPA—DRD5—central nervous system—migraine	0.000453	0.0116	CbGeAlD
L-DOPA—SLC7A5—nervous system—migraine	0.000438	0.0112	CbGeAlD
L-DOPA—SLC7A8—brain—migraine	0.000432	0.0111	CbGeAlD
L-DOPA—SLC7A5—central nervous system—migraine	0.000422	0.0108	CbGeAlD
L-DOPA—SLC7A5—cerebellum—migraine	0.000412	0.0106	CbGeAlD
L-DOPA—DRD2—brainstem—migraine	0.000405	0.0104	CbGeAlD
L-DOPA—Dopamine—HTR7—migraine	0.000387	0.311	CrCbGaD
L-DOPA—DRD3—brain—migraine	0.000383	0.00984	CbGeAlD
L-DOPA—DRD1—head—migraine	0.000379	0.00973	CbGeAlD
L-DOPA—DDC—brain—migraine	0.000374	0.00959	CbGeAlD
L-DOPA—DRD5—brain—migraine	0.000359	0.00923	CbGeAlD
L-DOPA—DRD1—nervous system—migraine	0.000359	0.00922	CbGeAlD
L-DOPA—DRD1—central nervous system—migraine	0.000346	0.00888	CbGeAlD
L-DOPA—SLC7A5—brain—migraine	0.000335	0.00859	CbGeAlD
L-DOPA—SLC16A10—cerebellum—migraine	0.000316	0.0081	CbGeAlD
L-DOPA—Epinephrine—TNF—migraine	0.000307	0.247	CrCbGaD
L-DOPA—Dopamine—HTR1A—migraine	0.000297	0.238	CrCbGaD
L-DOPA—DRD1—brain—migraine	0.000275	0.00705	CbGeAlD
L-DOPA—Dopamine—SLC6A4—migraine	0.000253	0.204	CrCbGaD
L-DOPA—CYP2D6—brainstem—migraine	0.000243	0.00625	CbGeAlD
L-DOPA—DRD2—head—migraine	0.000224	0.00575	CbGeAlD
L-DOPA—DRD2—nervous system—migraine	0.000212	0.00545	CbGeAlD
L-DOPA—DRD2—central nervous system—migraine	0.000204	0.00525	CbGeAlD
L-DOPA—DRD2—cerebellum—migraine	0.0002	0.00513	CbGeAlD
L-DOPA—DRD2—brain—migraine	0.000162	0.00416	CbGeAlD
L-DOPA—Back pain—Valproic Acid—migraine	0.000162	0.00122	CcSEcCtD
L-DOPA—Headache—Amitriptyline—migraine	0.000161	0.00122	CcSEcCtD
L-DOPA—Muscle spasms—Valproic Acid—migraine	0.000161	0.00122	CcSEcCtD
L-DOPA—Rhinitis—Gabapentin—migraine	0.00016	0.00121	CcSEcCtD
L-DOPA—Haemorrhage—Gabapentin—migraine	0.000159	0.0012	CcSEcCtD
L-DOPA—Feeling abnormal—Verapamil—migraine	0.000159	0.0012	CcSEcCtD
L-DOPA—Hallucination—Gabapentin—migraine	0.000159	0.0012	CcSEcCtD
L-DOPA—Hypoaesthesia—Gabapentin—migraine	0.000159	0.0012	CcSEcCtD
L-DOPA—Vision blurred—Valproic Acid—migraine	0.000158	0.00119	CcSEcCtD
L-DOPA—Urinary tract disorder—Gabapentin—migraine	0.000157	0.00119	CcSEcCtD
L-DOPA—Tremor—Valproic Acid—migraine	0.000157	0.00118	CcSEcCtD
L-DOPA—Urethral disorder—Gabapentin—migraine	0.000156	0.00118	CcSEcCtD
L-DOPA—Upper respiratory tract infection—Topiramate—migraine	0.000156	0.00118	CcSEcCtD
L-DOPA—Ill-defined disorder—Valproic Acid—migraine	0.000155	0.00117	CcSEcCtD
L-DOPA—Pollakiuria—Topiramate—migraine	0.000155	0.00117	CcSEcCtD
L-DOPA—Anaemia—Valproic Acid—migraine	0.000155	0.00117	CcSEcCtD
L-DOPA—Hypersensitivity—Propranolol—migraine	0.000154	0.00117	CcSEcCtD
L-DOPA—Agitation—Valproic Acid—migraine	0.000154	0.00116	CcSEcCtD
L-DOPA—Urticaria—Verapamil—migraine	0.000153	0.00116	CcSEcCtD
L-DOPA—Angioedema—Valproic Acid—migraine	0.000153	0.00116	CcSEcCtD
L-DOPA—Arrhythmia—Timolol—migraine	0.000153	0.00116	CcSEcCtD
L-DOPA—Nausea—Amitriptyline—migraine	0.000153	0.00115	CcSEcCtD
L-DOPA—Weight increased—Topiramate—migraine	0.000153	0.00115	CcSEcCtD
L-DOPA—Weight decreased—Topiramate—migraine	0.000152	0.00115	CcSEcCtD
L-DOPA—Alopecia—Timolol—migraine	0.000151	0.00114	CcSEcCtD
L-DOPA—Malaise—Valproic Acid—migraine	0.000151	0.00114	CcSEcCtD
L-DOPA—Asthenia—Propranolol—migraine	0.00015	0.00114	CcSEcCtD
L-DOPA—Mental disorder—Timolol—migraine	0.00015	0.00113	CcSEcCtD
L-DOPA—Leukopenia—Valproic Acid—migraine	0.00015	0.00113	CcSEcCtD
L-DOPA—Depression—Topiramate—migraine	0.000149	0.00113	CcSEcCtD
L-DOPA—Palpitations—Valproic Acid—migraine	0.000148	0.00112	CcSEcCtD
L-DOPA—Neuropathy peripheral—Topiramate—migraine	0.000146	0.00111	CcSEcCtD
L-DOPA—Tension—Timolol—migraine	0.000146	0.0011	CcSEcCtD
L-DOPA—Cough—Valproic Acid—migraine	0.000146	0.0011	CcSEcCtD
L-DOPA—Dysgeusia—Timolol—migraine	0.000146	0.0011	CcSEcCtD
L-DOPA—Urinary tract infection—Topiramate—migraine	0.000145	0.0011	CcSEcCtD
L-DOPA—Nervousness—Timolol—migraine	0.000145	0.00109	CcSEcCtD
L-DOPA—Hypertension—Valproic Acid—migraine	0.000145	0.00109	CcSEcCtD
L-DOPA—Diarrhoea—Propranolol—migraine	0.000143	0.00108	CcSEcCtD
L-DOPA—Chest pain—Valproic Acid—migraine	0.000143	0.00108	CcSEcCtD
L-DOPA—Anxiety—Valproic Acid—migraine	0.000142	0.00107	CcSEcCtD
L-DOPA—Hypersensitivity—Verapamil—migraine	0.000142	0.00107	CcSEcCtD
L-DOPA—Alopecia—Gabapentin—migraine	0.000141	0.00106	CcSEcCtD
L-DOPA—Discomfort—Valproic Acid—migraine	0.000141	0.00106	CcSEcCtD
L-DOPA—Vision blurred—Timolol—migraine	0.00014	0.00106	CcSEcCtD
L-DOPA—Mental disorder—Gabapentin—migraine	0.00014	0.00106	CcSEcCtD
L-DOPA—Agranulocytosis—Topiramate—migraine	0.000139	0.00105	CcSEcCtD
L-DOPA—Dry mouth—Valproic Acid—migraine	0.000139	0.00105	CcSEcCtD
L-DOPA—Dizziness—Propranolol—migraine	0.000139	0.00105	CcSEcCtD
L-DOPA—Asthenia—Verapamil—migraine	0.000138	0.00104	CcSEcCtD
L-DOPA—Confusional state—Valproic Acid—migraine	0.000138	0.00104	CcSEcCtD
L-DOPA—Flatulence—Gabapentin—migraine	0.000137	0.00103	CcSEcCtD
L-DOPA—Oedema—Valproic Acid—migraine	0.000137	0.00103	CcSEcCtD
L-DOPA—Pruritus—Verapamil—migraine	0.000136	0.00103	CcSEcCtD
L-DOPA—Tension—Gabapentin—migraine	0.000136	0.00103	CcSEcCtD
L-DOPA—Angioedema—Timolol—migraine	0.000136	0.00103	CcSEcCtD
L-DOPA—Dysgeusia—Gabapentin—migraine	0.000136	0.00103	CcSEcCtD
L-DOPA—Haemoglobin—Topiramate—migraine	0.000135	0.00102	CcSEcCtD
L-DOPA—Nervousness—Gabapentin—migraine	0.000135	0.00102	CcSEcCtD
L-DOPA—CYP2D6—head—migraine	0.000135	0.00345	CbGeAlD
L-DOPA—Rhinitis—Topiramate—migraine	0.000134	0.00102	CcSEcCtD
L-DOPA—Back pain—Gabapentin—migraine	0.000134	0.00101	CcSEcCtD
L-DOPA—Haemorrhage—Topiramate—migraine	0.000134	0.00101	CcSEcCtD
L-DOPA—Thrombocytopenia—Valproic Acid—migraine	0.000134	0.00101	CcSEcCtD
L-DOPA—Syncope—Timolol—migraine	0.000134	0.00101	CcSEcCtD
L-DOPA—Hallucination—Topiramate—migraine	0.000133	0.00101	CcSEcCtD
L-DOPA—Hypoaesthesia—Topiramate—migraine	0.000133	0.00101	CcSEcCtD
L-DOPA—Muscle spasms—Gabapentin—migraine	0.000133	0.00101	CcSEcCtD
L-DOPA—Vomiting—Propranolol—migraine	0.000133	0.00101	CcSEcCtD
L-DOPA—Urinary tract disorder—Topiramate—migraine	0.000132	0.001	CcSEcCtD
L-DOPA—Hyperhidrosis—Valproic Acid—migraine	0.000132	0.000998	CcSEcCtD
L-DOPA—Rash—Propranolol—migraine	0.000132	0.000998	CcSEcCtD
L-DOPA—Dermatitis—Propranolol—migraine	0.000132	0.000997	CcSEcCtD
L-DOPA—Diarrhoea—Verapamil—migraine	0.000132	0.000996	CcSEcCtD
L-DOPA—Palpitations—Timolol—migraine	0.000132	0.000995	CcSEcCtD
L-DOPA—Urethral disorder—Topiramate—migraine	0.000131	0.000993	CcSEcCtD
L-DOPA—Loss of consciousness—Timolol—migraine	0.000131	0.00099	CcSEcCtD
L-DOPA—Vision blurred—Gabapentin—migraine	0.000131	0.000988	CcSEcCtD
L-DOPA—Anorexia—Valproic Acid—migraine	0.00013	0.000984	CcSEcCtD
L-DOPA—Cough—Timolol—migraine	0.00013	0.000982	CcSEcCtD
L-DOPA—Tremor—Gabapentin—migraine	0.00013	0.000982	CcSEcCtD
L-DOPA—Ill-defined disorder—Gabapentin—migraine	0.000129	0.000973	CcSEcCtD
L-DOPA—Hypertension—Timolol—migraine	0.000129	0.000972	CcSEcCtD
L-DOPA—Anaemia—Gabapentin—migraine	0.000128	0.000969	CcSEcCtD
L-DOPA—Hypotension—Valproic Acid—migraine	0.000128	0.000964	CcSEcCtD
L-DOPA—Agitation—Gabapentin—migraine	0.000128	0.000963	CcSEcCtD
L-DOPA—CYP2D6—nervous system—migraine	0.000128	0.00327	CbGeAlD
L-DOPA—Dizziness—Verapamil—migraine	0.000127	0.000963	CcSEcCtD
L-DOPA—Chest pain—Timolol—migraine	0.000127	0.000959	CcSEcCtD
L-DOPA—Angioedema—Gabapentin—migraine	0.000127	0.000958	CcSEcCtD
L-DOPA—Anxiety—Timolol—migraine	0.000126	0.000955	CcSEcCtD
L-DOPA—Discomfort—Timolol—migraine	0.000125	0.000947	CcSEcCtD
L-DOPA—Malaise—Gabapentin—migraine	0.000125	0.000945	CcSEcCtD
L-DOPA—Flushing—Topiramate—migraine	0.000124	0.00094	CcSEcCtD
L-DOPA—Syncope—Gabapentin—migraine	0.000124	0.00094	CcSEcCtD
L-DOPA—Nausea—Propranolol—migraine	0.000124	0.00094	CcSEcCtD
L-DOPA—Leukopenia—Gabapentin—migraine	0.000124	0.000938	CcSEcCtD
L-DOPA—Dry mouth—Timolol—migraine	0.000124	0.000937	CcSEcCtD
L-DOPA—Insomnia—Valproic Acid—migraine	0.000124	0.000934	CcSEcCtD
L-DOPA—CYP2D6—central nervous system—migraine	0.000123	0.00315	CbGeAlD
L-DOPA—Paraesthesia—Valproic Acid—migraine	0.000123	0.000927	CcSEcCtD
L-DOPA—Palpitations—Gabapentin—migraine	0.000123	0.000927	CcSEcCtD
L-DOPA—Confusional state—Timolol—migraine	0.000123	0.000926	CcSEcCtD
L-DOPA—Vomiting—Verapamil—migraine	0.000123	0.000926	CcSEcCtD
L-DOPA—Loss of consciousness—Gabapentin—migraine	0.000122	0.000921	CcSEcCtD
L-DOPA—Dyspnoea—Valproic Acid—migraine	0.000122	0.00092	CcSEcCtD
L-DOPA—Oedema—Timolol—migraine	0.000122	0.000919	CcSEcCtD
L-DOPA—Rash—Verapamil—migraine	0.000122	0.000918	CcSEcCtD
L-DOPA—Somnolence—Valproic Acid—migraine	0.000121	0.000918	CcSEcCtD
L-DOPA—Dermatitis—Verapamil—migraine	0.000121	0.000917	CcSEcCtD
L-DOPA—Cough—Gabapentin—migraine	0.000121	0.000915	CcSEcCtD
L-DOPA—Headache—Verapamil—migraine	0.000121	0.000912	CcSEcCtD
L-DOPA—Dyspepsia—Valproic Acid—migraine	0.00012	0.000909	CcSEcCtD
L-DOPA—Convulsion—Gabapentin—migraine	0.00012	0.000908	CcSEcCtD
L-DOPA—CYP2D6—cerebellum—migraine	0.00012	0.00308	CbGeAlD
L-DOPA—Hypertension—Gabapentin—migraine	0.00012	0.000905	CcSEcCtD
L-DOPA—Shock—Timolol—migraine	0.00012	0.000904	CcSEcCtD
L-DOPA—Decreased appetite—Valproic Acid—migraine	0.000119	0.000897	CcSEcCtD
L-DOPA—Alopecia—Topiramate—migraine	0.000119	0.000895	CcSEcCtD
L-DOPA—Chest pain—Gabapentin—migraine	0.000118	0.000893	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Valproic Acid—migraine	0.000118	0.000891	CcSEcCtD
L-DOPA—Fatigue—Valproic Acid—migraine	0.000118	0.00089	CcSEcCtD
L-DOPA—Anxiety—Gabapentin—migraine	0.000118	0.00089	CcSEcCtD
L-DOPA—Hyperhidrosis—Timolol—migraine	0.000118	0.000888	CcSEcCtD
L-DOPA—Mental disorder—Topiramate—migraine	0.000118	0.000888	CcSEcCtD
L-DOPA—Pain—Valproic Acid—migraine	0.000117	0.000883	CcSEcCtD
L-DOPA—Constipation—Valproic Acid—migraine	0.000117	0.000883	CcSEcCtD
L-DOPA—Discomfort—Gabapentin—migraine	0.000117	0.000882	CcSEcCtD
L-DOPA—Anorexia—Timolol—migraine	0.000116	0.000876	CcSEcCtD
L-DOPA—Dry mouth—Gabapentin—migraine	0.000116	0.000873	CcSEcCtD
L-DOPA—Flatulence—Topiramate—migraine	0.000115	0.000869	CcSEcCtD
L-DOPA—Tension—Topiramate—migraine	0.000115	0.000866	CcSEcCtD
L-DOPA—Nausea—Verapamil—migraine	0.000114	0.000865	CcSEcCtD
L-DOPA—Dysgeusia—Topiramate—migraine	0.000114	0.000864	CcSEcCtD
L-DOPA—Confusional state—Gabapentin—migraine	0.000114	0.000863	CcSEcCtD
L-DOPA—Hypotension—Timolol—migraine	0.000114	0.000859	CcSEcCtD
L-DOPA—Nervousness—Topiramate—migraine	0.000113	0.000857	CcSEcCtD
L-DOPA—Oedema—Gabapentin—migraine	0.000113	0.000856	CcSEcCtD
L-DOPA—Back pain—Topiramate—migraine	0.000113	0.000853	CcSEcCtD
L-DOPA—Feeling abnormal—Valproic Acid—migraine	0.000113	0.000851	CcSEcCtD
L-DOPA—Muscle spasms—Topiramate—migraine	0.000112	0.000848	CcSEcCtD
L-DOPA—Gastrointestinal pain—Valproic Acid—migraine	0.000112	0.000844	CcSEcCtD
L-DOPA—Shock—Gabapentin—migraine	0.000111	0.000842	CcSEcCtD
L-DOPA—Thrombocytopenia—Gabapentin—migraine	0.000111	0.000838	CcSEcCtD
L-DOPA—Vision blurred—Topiramate—migraine	0.00011	0.000831	CcSEcCtD
L-DOPA—Insomnia—Timolol—migraine	0.00011	0.000831	CcSEcCtD
L-DOPA—Hyperhidrosis—Gabapentin—migraine	0.00011	0.000827	CcSEcCtD
L-DOPA—Tremor—Topiramate—migraine	0.000109	0.000826	CcSEcCtD
L-DOPA—Paraesthesia—Timolol—migraine	0.000109	0.000825	CcSEcCtD
L-DOPA—Urticaria—Valproic Acid—migraine	0.000109	0.00082	CcSEcCtD
L-DOPA—Dyspnoea—Timolol—migraine	0.000108	0.000819	CcSEcCtD
L-DOPA—Ill-defined disorder—Topiramate—migraine	0.000108	0.000818	CcSEcCtD
L-DOPA—Somnolence—Timolol—migraine	0.000108	0.000817	CcSEcCtD
L-DOPA—Abdominal pain—Valproic Acid—migraine	0.000108	0.000816	CcSEcCtD
L-DOPA—Anorexia—Gabapentin—migraine	0.000108	0.000816	CcSEcCtD
L-DOPA—Anaemia—Topiramate—migraine	0.000108	0.000815	CcSEcCtD
L-DOPA—Agitation—Topiramate—migraine	0.000107	0.000811	CcSEcCtD
L-DOPA—Dyspepsia—Timolol—migraine	0.000107	0.000809	CcSEcCtD
L-DOPA—Hypotension—Gabapentin—migraine	0.000106	0.0008	CcSEcCtD
L-DOPA—Decreased appetite—Timolol—migraine	0.000106	0.000799	CcSEcCtD
L-DOPA—Malaise—Topiramate—migraine	0.000105	0.000795	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Timolol—migraine	0.000105	0.000793	CcSEcCtD
L-DOPA—Fatigue—Timolol—migraine	0.000105	0.000792	CcSEcCtD
L-DOPA—Syncope—Topiramate—migraine	0.000105	0.000791	CcSEcCtD
L-DOPA—Leukopenia—Topiramate—migraine	0.000105	0.00079	CcSEcCtD
L-DOPA—Pain—Timolol—migraine	0.000104	0.000786	CcSEcCtD
L-DOPA—Palpitations—Topiramate—migraine	0.000103	0.000779	CcSEcCtD
L-DOPA—Loss of consciousness—Topiramate—migraine	0.000103	0.000775	CcSEcCtD
L-DOPA—Insomnia—Gabapentin—migraine	0.000102	0.000774	CcSEcCtD
L-DOPA—Cough—Topiramate—migraine	0.000102	0.00077	CcSEcCtD
L-DOPA—Paraesthesia—Gabapentin—migraine	0.000102	0.000768	CcSEcCtD
L-DOPA—Convulsion—Topiramate—migraine	0.000101	0.000764	CcSEcCtD
L-DOPA—Dyspnoea—Gabapentin—migraine	0.000101	0.000763	CcSEcCtD
L-DOPA—Hypertension—Topiramate—migraine	0.000101	0.000762	CcSEcCtD
L-DOPA—Somnolence—Gabapentin—migraine	0.000101	0.000761	CcSEcCtD
L-DOPA—Hypersensitivity—Valproic Acid—migraine	0.000101	0.00076	CcSEcCtD
L-DOPA—Feeling abnormal—Timolol—migraine	0.0001	0.000757	CcSEcCtD
L-DOPA—Dyspepsia—Gabapentin—migraine	9.97e-05	0.000753	CcSEcCtD
L-DOPA—Gastrointestinal pain—Timolol—migraine	9.95e-05	0.000751	CcSEcCtD
L-DOPA—Chest pain—Topiramate—migraine	9.94e-05	0.000751	CcSEcCtD
L-DOPA—Anxiety—Topiramate—migraine	9.91e-05	0.000748	CcSEcCtD
L-DOPA—Decreased appetite—Gabapentin—migraine	9.85e-05	0.000744	CcSEcCtD
L-DOPA—Discomfort—Topiramate—migraine	9.82e-05	0.000742	CcSEcCtD
L-DOPA—Asthenia—Valproic Acid—migraine	9.8e-05	0.000741	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Gabapentin—migraine	9.78e-05	0.000739	CcSEcCtD
L-DOPA—Fatigue—Gabapentin—migraine	9.77e-05	0.000738	CcSEcCtD
L-DOPA—CYP2D6—brain—migraine	9.75e-05	0.0025	CbGeAlD
L-DOPA—Dry mouth—Topiramate—migraine	9.72e-05	0.000734	CcSEcCtD
L-DOPA—Pain—Gabapentin—migraine	9.69e-05	0.000732	CcSEcCtD
L-DOPA—Constipation—Gabapentin—migraine	9.69e-05	0.000732	CcSEcCtD
L-DOPA—Pruritus—Valproic Acid—migraine	9.67e-05	0.00073	CcSEcCtD
L-DOPA—Urticaria—Timolol—migraine	9.66e-05	0.00073	CcSEcCtD
L-DOPA—Abdominal pain—Timolol—migraine	9.62e-05	0.000726	CcSEcCtD
L-DOPA—Confusional state—Topiramate—migraine	9.61e-05	0.000726	CcSEcCtD
L-DOPA—Oedema—Topiramate—migraine	9.53e-05	0.00072	CcSEcCtD
L-DOPA—Shock—Topiramate—migraine	9.38e-05	0.000708	CcSEcCtD
L-DOPA—Diarrhoea—Valproic Acid—migraine	9.35e-05	0.000706	CcSEcCtD
L-DOPA—Feeling abnormal—Gabapentin—migraine	9.34e-05	0.000705	CcSEcCtD
L-DOPA—Thrombocytopenia—Topiramate—migraine	9.33e-05	0.000705	CcSEcCtD
L-DOPA—Gastrointestinal pain—Gabapentin—migraine	9.26e-05	0.0007	CcSEcCtD
L-DOPA—Hyperhidrosis—Topiramate—migraine	9.21e-05	0.000696	CcSEcCtD
L-DOPA—Anorexia—Topiramate—migraine	9.08e-05	0.000686	CcSEcCtD
L-DOPA—Dizziness—Valproic Acid—migraine	9.04e-05	0.000683	CcSEcCtD
L-DOPA—Urticaria—Gabapentin—migraine	9e-05	0.00068	CcSEcCtD
L-DOPA—Hypersensitivity—Timolol—migraine	8.96e-05	0.000677	CcSEcCtD
L-DOPA—Abdominal pain—Gabapentin—migraine	8.96e-05	0.000676	CcSEcCtD
L-DOPA—Hypotension—Topiramate—migraine	8.91e-05	0.000673	CcSEcCtD
L-DOPA—Asthenia—Timolol—migraine	8.73e-05	0.000659	CcSEcCtD
L-DOPA—Vomiting—Valproic Acid—migraine	8.69e-05	0.000656	CcSEcCtD
L-DOPA—Insomnia—Topiramate—migraine	8.62e-05	0.000651	CcSEcCtD
L-DOPA—Rash—Valproic Acid—migraine	8.62e-05	0.000651	CcSEcCtD
L-DOPA—Dermatitis—Valproic Acid—migraine	8.61e-05	0.00065	CcSEcCtD
L-DOPA—Pruritus—Timolol—migraine	8.61e-05	0.00065	CcSEcCtD
L-DOPA—Headache—Valproic Acid—migraine	8.56e-05	0.000647	CcSEcCtD
L-DOPA—Paraesthesia—Topiramate—migraine	8.56e-05	0.000646	CcSEcCtD
L-DOPA—Dyspnoea—Topiramate—migraine	8.5e-05	0.000642	CcSEcCtD
L-DOPA—Somnolence—Topiramate—migraine	8.47e-05	0.00064	CcSEcCtD
L-DOPA—Dyspepsia—Topiramate—migraine	8.39e-05	0.000634	CcSEcCtD
L-DOPA—Hypersensitivity—Gabapentin—migraine	8.35e-05	0.00063	CcSEcCtD
L-DOPA—Diarrhoea—Timolol—migraine	8.32e-05	0.000629	CcSEcCtD
L-DOPA—Decreased appetite—Topiramate—migraine	8.28e-05	0.000626	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Topiramate—migraine	8.23e-05	0.000622	CcSEcCtD
L-DOPA—Fatigue—Topiramate—migraine	8.22e-05	0.000621	CcSEcCtD
L-DOPA—Pain—Topiramate—migraine	8.15e-05	0.000616	CcSEcCtD
L-DOPA—Constipation—Topiramate—migraine	8.15e-05	0.000616	CcSEcCtD
L-DOPA—Asthenia—Gabapentin—migraine	8.13e-05	0.000614	CcSEcCtD
L-DOPA—Nausea—Valproic Acid—migraine	8.12e-05	0.000613	CcSEcCtD
L-DOPA—Dizziness—Timolol—migraine	8.04e-05	0.000608	CcSEcCtD
L-DOPA—Pruritus—Gabapentin—migraine	8.01e-05	0.000605	CcSEcCtD
L-DOPA—Feeling abnormal—Topiramate—migraine	7.85e-05	0.000593	CcSEcCtD
L-DOPA—Gastrointestinal pain—Topiramate—migraine	7.79e-05	0.000589	CcSEcCtD
L-DOPA—Diarrhoea—Gabapentin—migraine	7.75e-05	0.000585	CcSEcCtD
L-DOPA—Vomiting—Timolol—migraine	7.73e-05	0.000584	CcSEcCtD
L-DOPA—Rash—Timolol—migraine	7.67e-05	0.000579	CcSEcCtD
L-DOPA—Dermatitis—Timolol—migraine	7.66e-05	0.000579	CcSEcCtD
L-DOPA—Headache—Timolol—migraine	7.62e-05	0.000576	CcSEcCtD
L-DOPA—Urticaria—Topiramate—migraine	7.57e-05	0.000572	CcSEcCtD
L-DOPA—Abdominal pain—Topiramate—migraine	7.53e-05	0.000569	CcSEcCtD
L-DOPA—Dizziness—Gabapentin—migraine	7.49e-05	0.000566	CcSEcCtD
L-DOPA—Nausea—Timolol—migraine	7.23e-05	0.000546	CcSEcCtD
L-DOPA—Vomiting—Gabapentin—migraine	7.2e-05	0.000544	CcSEcCtD
L-DOPA—Rash—Gabapentin—migraine	7.14e-05	0.00054	CcSEcCtD
L-DOPA—Dermatitis—Gabapentin—migraine	7.14e-05	0.000539	CcSEcCtD
L-DOPA—Headache—Gabapentin—migraine	7.1e-05	0.000536	CcSEcCtD
L-DOPA—Hypersensitivity—Topiramate—migraine	7.02e-05	0.00053	CcSEcCtD
L-DOPA—Asthenia—Topiramate—migraine	6.84e-05	0.000517	CcSEcCtD
L-DOPA—Pruritus—Topiramate—migraine	6.74e-05	0.000509	CcSEcCtD
L-DOPA—Nausea—Gabapentin—migraine	6.73e-05	0.000508	CcSEcCtD
L-DOPA—Diarrhoea—Topiramate—migraine	6.52e-05	0.000493	CcSEcCtD
L-DOPA—Dizziness—Topiramate—migraine	6.3e-05	0.000476	CcSEcCtD
L-DOPA—Vomiting—Topiramate—migraine	6.06e-05	0.000458	CcSEcCtD
L-DOPA—Rash—Topiramate—migraine	6.01e-05	0.000454	CcSEcCtD
L-DOPA—Dermatitis—Topiramate—migraine	6e-05	0.000453	CcSEcCtD
L-DOPA—Headache—Topiramate—migraine	5.97e-05	0.000451	CcSEcCtD
L-DOPA—DRD3—GPCR ligand binding—HTR1B—migraine	5.94e-05	0.000846	CbGpPWpGaD
L-DOPA—DRD4—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	5.85e-05	0.000833	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—RAMP1—migraine	5.84e-05	0.000831	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CALCRL—migraine	5.84e-05	0.000831	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—CALCA—migraine	5.83e-05	0.000829	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—HTR2B—migraine	5.8e-05	0.000826	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—HTR1A—migraine	5.8e-05	0.000825	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	5.75e-05	0.000818	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—HTR1A—migraine	5.72e-05	0.000814	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—TAC1—migraine	5.71e-05	0.000813	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—NPS—migraine	5.71e-05	0.000813	CbGpPWpGaD
L-DOPA—DRD2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	5.68e-05	0.000808	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—HTR1D—migraine	5.67e-05	0.000807	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	5.66e-05	0.000806	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	5.66e-05	0.000806	CbGpPWpGaD
L-DOPA—Nausea—Topiramate—migraine	5.66e-05	0.000428	CcSEcCtD
L-DOPA—DRD3—GPCR ligand binding—TAC1—migraine	5.63e-05	0.000802	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—NPS—migraine	5.63e-05	0.000802	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—HTR1D—migraine	5.62e-05	0.0008	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—HTR2C—migraine	5.6e-05	0.000797	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	5.55e-05	0.00079	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—HTR1D—migraine	5.54e-05	0.000789	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—HTR2C—migraine	5.53e-05	0.000787	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—HTR7—migraine	5.45e-05	0.000776	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—EDNRA—migraine	5.45e-05	0.000775	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	5.4e-05	0.000769	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—EDNRA—migraine	5.38e-05	0.000765	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CALCRL—migraine	5.3e-05	0.000755	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—RAMP1—migraine	5.3e-05	0.000755	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—HTR2B—migraine	5.27e-05	0.00075	CbGpPWpGaD
L-DOPA—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	5.27e-05	0.00075	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—CALCA—migraine	5.24e-05	0.000746	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—HTR2B—migraine	5.22e-05	0.000744	CbGpPWpGaD
L-DOPA—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	5.2e-05	0.00074	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—CALCA—migraine	5.17e-05	0.000736	CbGpPWpGaD
L-DOPA—DRD5—GPCR ligand binding—HTR2A—migraine	5.17e-05	0.000736	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—HTR2B—migraine	5.15e-05	0.000734	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—HTR1B—migraine	5.12e-05	0.000729	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—HTR1D—migraine	5.1e-05	0.000726	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—HTR1D—migraine	5.03e-05	0.000717	CbGpPWpGaD
L-DOPA—DRD4—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	5.01e-05	0.000713	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—HTR1A—migraine	4.93e-05	0.000702	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—HTR7—migraine	4.91e-05	0.000698	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	4.86e-05	0.000692	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—TAC1—migraine	4.86e-05	0.000691	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—NPS—migraine	4.86e-05	0.000691	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—HTR7—migraine	4.84e-05	0.000689	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—HTR2C—migraine	4.76e-05	0.000678	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—HTR2B—migraine	4.74e-05	0.000675	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—HTR2B—migraine	4.68e-05	0.000666	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—HTR1B—migraine	4.65e-05	0.000662	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—EDNRA—migraine	4.63e-05	0.00066	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—RAMP1—migraine	4.61e-05	0.000656	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CALCRL—migraine	4.61e-05	0.000656	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—HTR1B—migraine	4.55e-05	0.000647	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HTR1D—migraine	4.54e-05	0.000646	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.51e-05	0.000642	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—HTR1A—migraine	4.48e-05	0.000637	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—CALCA—migraine	4.46e-05	0.000635	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.45e-05	0.000634	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—TAC1—migraine	4.41e-05	0.000628	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—NPS—migraine	4.41e-05	0.000628	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—HTR1A—migraine	4.38e-05	0.000623	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—HTR2C—migraine	4.33e-05	0.000616	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—NPS—migraine	4.31e-05	0.000614	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—TAC1—migraine	4.31e-05	0.000614	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—HTR1D—migraine	4.24e-05	0.000604	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—HTR2C—migraine	4.23e-05	0.000602	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HTR2B—migraine	4.22e-05	0.0006	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—EDNRA—migraine	4.21e-05	0.000599	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—HTR7—migraine	4.17e-05	0.000594	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—RAMP1—migraine	4.15e-05	0.00059	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CALCRL—migraine	4.15e-05	0.00059	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—EDNRA—migraine	4.11e-05	0.000585	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—RAMP1—migraine	4.09e-05	0.000583	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CALCRL—migraine	4.09e-05	0.000583	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—CALCA—migraine	4.05e-05	0.000577	CbGpPWpGaD
L-DOPA—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	3.98e-05	0.000566	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—CALCA—migraine	3.96e-05	0.000564	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—HTR2B—migraine	3.94e-05	0.000561	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HTR1D—migraine	3.85e-05	0.000548	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—HTR2A—migraine	3.82e-05	0.000543	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—HTR7—migraine	3.79e-05	0.000539	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—HTR1B—migraine	3.78e-05	0.000538	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—LRP1—migraine	3.71e-05	0.000529	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—HTR7—migraine	3.7e-05	0.000527	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—HTR1A—migraine	3.64e-05	0.000518	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—NPS—migraine	3.58e-05	0.00051	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—TAC1—migraine	3.58e-05	0.00051	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HTR2B—migraine	3.58e-05	0.00051	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—HTR2C—migraine	3.52e-05	0.0005	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—HTR2A—migraine	3.44e-05	0.000489	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—HTR1B—migraine	3.43e-05	0.000489	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—EDNRA—migraine	3.42e-05	0.000487	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	3.41e-05	0.000485	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—HTR1B—migraine	3.4e-05	0.000485	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—HTR2A—migraine	3.39e-05	0.000482	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—HTR1B—migraine	3.36e-05	0.000478	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HTR1D—migraine	3.35e-05	0.000477	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—HTR1A—migraine	3.31e-05	0.000471	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—CALCA—migraine	3.29e-05	0.000469	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—HTR1A—migraine	3.28e-05	0.000466	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—NPS—migraine	3.26e-05	0.000463	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—TAC1—migraine	3.26e-05	0.000463	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—HTR1A—migraine	3.23e-05	0.00046	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—TAC1—migraine	3.23e-05	0.000459	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—NPS—migraine	3.23e-05	0.000459	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—HTR2C—migraine	3.19e-05	0.000454	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—NPS—migraine	3.18e-05	0.000453	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—TAC1—migraine	3.18e-05	0.000453	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—HTR2C—migraine	3.16e-05	0.00045	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CALCRL—migraine	3.13e-05	0.000446	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—RAMP1—migraine	3.13e-05	0.000446	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—HTR2C—migraine	3.12e-05	0.000444	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HTR2B—migraine	3.11e-05	0.000443	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—EDNRA—migraine	3.11e-05	0.000442	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—HTR1B—migraine	3.09e-05	0.00044	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—HTR7—migraine	3.08e-05	0.000438	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—EDNRA—migraine	3.08e-05	0.000438	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—HTR1B—migraine	3.05e-05	0.000434	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—EDNRA—migraine	3.04e-05	0.000432	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HTR1D—migraine	3.01e-05	0.000429	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CALCA—migraine	2.99e-05	0.000426	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—HTR1A—migraine	2.98e-05	0.000424	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HTR1D—migraine	2.97e-05	0.000423	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—CALCA—migraine	2.96e-05	0.000422	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—HTR1A—migraine	2.94e-05	0.000418	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—TAC1—migraine	2.93e-05	0.000417	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—NPS—migraine	2.93e-05	0.000417	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CALCA—migraine	2.92e-05	0.000416	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—HTR2A—migraine	2.92e-05	0.000416	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—TAC1—migraine	2.89e-05	0.000412	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—NPS—migraine	2.89e-05	0.000412	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—HTR2C—migraine	2.87e-05	0.000409	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NOTCH4—migraine	2.85e-05	0.000406	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—HTR2C—migraine	2.84e-05	0.000404	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HTR2B—migraine	2.8e-05	0.000399	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—HTR7—migraine	2.8e-05	0.000398	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—EDNRA—migraine	2.8e-05	0.000398	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—HTR7—migraine	2.77e-05	0.000395	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HTR2B—migraine	2.76e-05	0.000394	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—EDNRA—migraine	2.76e-05	0.000393	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HTR1B—migraine	2.75e-05	0.000391	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—LRP1—migraine	2.74e-05	0.00039	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—HTR7—migraine	2.74e-05	0.000389	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CALCA—migraine	2.69e-05	0.000383	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CALCA—migraine	2.66e-05	0.000378	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—HTR2A—migraine	2.65e-05	0.000378	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HTR1A—migraine	2.65e-05	0.000377	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—PGR—migraine	2.61e-05	0.000371	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TAC1—migraine	2.61e-05	0.000371	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NPS—migraine	2.61e-05	0.000371	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—HTR2A—migraine	2.59e-05	0.000369	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—HTR1B—migraine	2.57e-05	0.000366	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HTR2C—migraine	2.56e-05	0.000364	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—HTR7—migraine	2.52e-05	0.000358	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—EDNRA—migraine	2.49e-05	0.000354	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—HTR7—migraine	2.48e-05	0.000354	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—HTR1A—migraine	2.47e-05	0.000352	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—LRP1—migraine	2.47e-05	0.000351	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—TAC1—migraine	2.44e-05	0.000347	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—NPS—migraine	2.44e-05	0.000347	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—LRP1—migraine	2.43e-05	0.000346	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NOTCH3—migraine	2.42e-05	0.000345	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CALCA—migraine	2.39e-05	0.000341	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—HTR2C—migraine	2.39e-05	0.00034	CbGpPWpGaD
L-DOPA—DDC—Metabolism—MTHFR—migraine	2.38e-05	0.000339	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HTR1B—migraine	2.33e-05	0.000332	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—EDNRA—migraine	2.32e-05	0.000331	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HTR1D—migraine	2.28e-05	0.000324	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HTR1A—migraine	2.25e-05	0.00032	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HTR7—migraine	2.24e-05	0.000319	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CALCA—migraine	2.24e-05	0.000318	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—TAC1—migraine	2.21e-05	0.000315	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—NPS—migraine	2.21e-05	0.000315	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HTR2C—migraine	2.17e-05	0.000309	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—HTR2A—migraine	2.16e-05	0.000307	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HTR2B—migraine	2.12e-05	0.000301	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—EDNRA—migraine	2.11e-05	0.0003	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NOTCH4—migraine	2.1e-05	0.000299	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—HTR7—migraine	2.09e-05	0.000298	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CALCA—migraine	2.03e-05	0.000289	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HTR1B—migraine	2.03e-05	0.000289	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—HTR2A—migraine	1.96e-05	0.000279	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HTR1A—migraine	1.95e-05	0.000278	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—HTR2A—migraine	1.94e-05	0.000276	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TGFBR2—migraine	1.93e-05	0.000274	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TAC1—migraine	1.92e-05	0.000274	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NPS—migraine	1.92e-05	0.000274	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PGR—migraine	1.92e-05	0.000274	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—HTR2A—migraine	1.92e-05	0.000273	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HTR7—migraine	1.9e-05	0.000271	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NOTCH4—migraine	1.89e-05	0.000269	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HTR2C—migraine	1.89e-05	0.000268	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NOTCH4—migraine	1.87e-05	0.000266	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—LRP1—migraine	1.86e-05	0.000265	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—EDNRA—migraine	1.83e-05	0.000261	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HTR1B—migraine	1.83e-05	0.00026	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HTR1B—migraine	1.8e-05	0.000256	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NOTCH3—migraine	1.79e-05	0.000254	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CALCA—migraine	1.77e-05	0.000251	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—HTR2A—migraine	1.76e-05	0.000251	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HTR1A—migraine	1.76e-05	0.00025	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—HTR2A—migraine	1.74e-05	0.000248	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HTR1A—migraine	1.73e-05	0.000247	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TAC1—migraine	1.73e-05	0.000246	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NPS—migraine	1.73e-05	0.000246	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PGR—migraine	1.73e-05	0.000246	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NPS—migraine	1.71e-05	0.000243	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PGR—migraine	1.71e-05	0.000243	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TAC1—migraine	1.71e-05	0.000243	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HTR2C—migraine	1.7e-05	0.000242	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HTR2C—migraine	1.68e-05	0.000238	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CACNA1A—migraine	1.66e-05	0.000236	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HTR7—migraine	1.65e-05	0.000235	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—EDNRA—migraine	1.65e-05	0.000235	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—EDNRA—migraine	1.63e-05	0.000232	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NOTCH3—migraine	1.61e-05	0.000229	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CALCA—migraine	1.59e-05	0.000226	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NOTCH3—migraine	1.59e-05	0.000226	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CALCA—migraine	1.57e-05	0.000223	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HTR2A—migraine	1.57e-05	0.000223	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HTR7—migraine	1.49e-05	0.000212	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HTR7—migraine	1.47e-05	0.000209	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—HTR2A—migraine	1.47e-05	0.000209	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NOTCH4—migraine	1.43e-05	0.000203	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TGFBR2—migraine	1.42e-05	0.000202	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—ESR1—migraine	1.39e-05	0.000198	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HTR1B—migraine	1.38e-05	0.000196	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HTR2A—migraine	1.33e-05	0.000189	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HTR1A—migraine	1.33e-05	0.000189	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PGR—migraine	1.31e-05	0.000186	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NPS—migraine	1.31e-05	0.000186	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TAC1—migraine	1.31e-05	0.000186	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HTR2C—migraine	1.28e-05	0.000182	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TGFBR2—migraine	1.28e-05	0.000182	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TGFBR2—migraine	1.26e-05	0.00018	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—EDNRA—migraine	1.25e-05	0.000177	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NOTCH3—migraine	1.22e-05	0.000173	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CALCA—migraine	1.2e-05	0.000171	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HTR2A—migraine	1.16e-05	0.000165	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HTR7—migraine	1.12e-05	0.00016	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HTR2A—migraine	1.04e-05	0.000148	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HTR2A—migraine	1.03e-05	0.000146	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—ESR1—migraine	1.03e-05	0.000146	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TGFBR2—migraine	9.67e-06	0.000138	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—ESR1—migraine	9.24e-06	0.000132	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—ESR1—migraine	9.12e-06	0.00013	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HTR2A—migraine	7.86e-06	0.000112	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ESR1—migraine	6.98e-06	9.93e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—MTHFR—migraine	5.48e-06	7.8e-05	CbGpPWpGaD
